OGEN | Oragenics Inc

0.51 -0.06 (-13.16%) 

Healthcare sector

• Summary
• Earnings Call
• Events
• Charts
• Historical Data
• Dividends
• Profile

Category: Consumer goods

• Industry: Biotechnology

Quick infos

Trade prices

• Volume:
• Market Cap:
• Prev closed:
• Open:
• High:
• Low:
• 52 week low:
• 52 week high:
• Dividends:

Top Stories (OGEN)

Earnings History

Date	EPS / Forecast	Revenue / Forecast
August 26, 2020	-0.11 / -0.09	- / -
August 12, 2020	- / -0.09	- / -
May 25, 2020	-0.08 / -0.08	- / -
February 14, 2020	-0.08 / -0.09	- / -
November 13, 2019	-0.08 / -0.09	- / -
view more

Historical Data

Date		Price		Open	High	Low		Vol	Change	ER
Nov 20, 2020		0.3990		0.3850	0.4099	0.3789		25.00M	-24.14%
Nov 19, 2020		0.5260		0.4700	0.5614	0.4638		6.96M	12.63%
Nov 18, 2020		0.4670		0.4850	0.4850	0.4600		1.12M	-4.11%
Nov 17, 2020		0.4870		0.4600	0.4900	0.4600		865.10K	4.78%
Nov 16, 2020		0.4648		0.4700	0.4761	0.4558		888.46K	-1.94%
Nov 13, 2020		0.4740		0.4800	0.4900	0.4640		987.03K	-1.25%
Nov 12, 2020		0.4800		0.4790	0.4912	0.4701		1.02M	-2.28%
Nov 11, 2020		0.4912		0.4500	0.5040	0.4401		3.60M	9.13%
Nov 10, 2020		0.4501		0.4722	0.4780	0.4500		1.78M	-4.17%
Nov 9, 2020		0.4697		0.4730	0.4920	0.4630		1.33M	-5.64%
view more

Show all

News

News for (OGEN)

• 
  Oragenics rallies on encouraging data supporting potential COVID-19 vaccine
  seekingalpha.com Jul 22, 2020 9:19 pm
• 
  Oragenics +13% on advancement of COVID-19 vaccine program
  seekingalpha.com Jul 10, 2020 7:51 pm
• 
  Oragenics inks deal to advance COVID-19 vaccine
  seekingalpha.com May 19, 2020 8:13 pm
• Oragenics, Inc. Receives Further Validation for Lantibiotic Compound OG716
  app.quotemedia.com Jan 28, 2019 9:37 pm
• 
  Oragenics enters the COVID-19 vaccine game; shares up 51% premarket
  seekingalpha.com May 16, 2020 4:01 am
• 
  Oragenics' AG013 flunks mid-stage study; shares down 50% premarket
  seekingalpha.com Apr 15, 2020 7:43 pm
• 
  Oragenics files for $50M equity offering
  seekingalpha.com Mar 5, 2020 5:06 am
• 
  Oragenics (OGEN) Investor Presentation - Slideshow
  seekingalpha.com Nov 15, 2019 5:06 am
• 
  Oragenics up 12% on advancement of oral mucositis candidate
  seekingalpha.com Aug 15, 2019 4:06 am
• 
  Oragenics collaborates with FIU to expand lantibiotic pipeline
  seekingalpha.com May 17, 2019 4:00 am
• 
  Oragenics closes $12.5M equity offering
  seekingalpha.com Mar 26, 2019 4:09 am
• 
  Oragenics -13.1% on proposed equity offering
  seekingalpha.com Mar 21, 2019 6:19 am
• 
  Oragenics up 23%
  seekingalpha.com Nov 30 11:22 pm
• 
  Oragenics reports Q3 results
  seekingalpha.com Nov 15 1:21 pm
• 
  Oragenics receives clearance to enroll patients into its Phase 2 trial of AG013 for oral mucositis
  seekingalpha.com Oct 17 9:35 pm
• 
  Oragenics adds to rally, up 46%
  seekingalpha.com Oct 1 11:04 pm
• 
  Premarket Losers as of 9:05 am (07/13/2018)
  seekingalpha.com Jul 13 9:17 pm
• 
  Oragenics prices equity offering; shares down 31% premarket
  seekingalpha.com Jul 13 8:43 pm
• 
  Oragenics files for equity offering
  seekingalpha.com Jul 6 7:30 pm
• 
  Oragenics' AG013 shows favorable safety profile in mid-stage OM study; shares up 34% premarket
  seekingalpha.com May 30 7:55 pm

Talk about Oragenics Inc below in comments section below.

Do you think you'll buy? Do you already have active trades now?

EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.

Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.